One Forte Tablet is a combination antibiotic formulation containing Ofloxacin 200 mg and Ornidazole 500 mg, indicated for the treatment of a broad spectrum of bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, exerts its bactericidal effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by causing DNA strand breakage and inhibiting nucleic acid synthesis. This synergistic combination is particularly useful in mixed infections involving both aerobic and anaerobic organisms, such as gastrointestinal infections, genitourinary tract infections, respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted infections. One Forte Tablet should be administered as prescribed by a healthcare professional, with dosage adjustments made based on the severity of infection and patient-specific factors including renal function. Caution is advised in patients with hypersensitivity to fluoroquinolones or nitroimidazoles, and potential side effects may include gastrointestinal disturbances, dizziness, headache, and hypersensitivity reactions. It is contraindicated in pregnancy and lactation unless deemed essential by a physician. Proper adherence to the prescribed regimen is critical to prevent the development of antibiotic resistance.